DUSTIN DEBOURGE: Open Payments
NPI 1720688914 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 6 payments from 5 companies in 2025. Trend: 2023 $329 · 2024 $498 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $138 |
| Gilead Sciences, Inc. | 1 | $111 |
| ViiV Healthcare Company | 1 | $72 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Viatris Specialty LLC | 1 | $20 |
Products named: INGREZZA, Biktarvy, APRETUDE, REXULTI, YUPELRI.
Industry payments across MO — which companies pay providers there.
